Clinical Trials Browser

Phase 1/2 × Interventional × iniparib × Clear all

NCT00687765 2022-09-14

Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma

Phase 1/2 Completed

Glioblastoma